IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
IPO Review
IPO Review
Vijaypd Ceutical caters to Pharmaceutical sector; distributor and supplier of the pharmaceutical products and consumer goods sectors, offering a comprehensive range of services. The API (Active Pharmaceutical Ingredients) sector is projected to grow at a CAGR of 7-8% by 2029, positioning India as a critical player in the global pharmaceutical supply chain.
Leverages advanced technology to deliver comprehensive healthcare solutions to pharmacies, nursing homes, and clinics across Western Suburban Mumbai, South Mumbai, Ratnagiri, Aurangabad and Akola. As of March 31, 2025, the customer base includes over 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations. Positioning itself to expand its market presence by diversifying into the manufacturing of active pharmaceutical ingredient.
| Revenue | ₹59.20 cr | ₹117.09 cr (+97.79%) | |
| PAT | ₹1.65 cr | ₹4.79 cr (+190.30%) | |
| PAT Margin | 2.79 % | 4.09 % (+46.59%) | |
| EBITDA | ₹4.86 cr | ₹9.36 cr (+92.59%) | |
| EBITDA Margin | 8.21 % | 7.99 % (-2.68%) | |
| ROE | 25.04 % | 14.89 % (-40.54%) | |
| ROCE | 14.61 % | 17.30 % (+18.41%) | |
| D/E | 3.71 | 0.68 (-81.67%) |
The company is into distribution of healthcare products to retail pharmacies, nursing homes and healthcare clinics in Maharashtra. Investment in technology at warehouses to enhance fulfilment rates, reliability and product availability. Samarth Software is utilised to ensure that inventory records are updated real-time and accurate. This system is also integrated to ensure that orders are processed in a timely manner.
PE Ratio: 14.23x Average Sector PE Ratio: 20.39x
| NII (HNI) Shares Offered: | 2608000 |
| Retail Shares Offered: | 2608000 |
| Total Shares Offered: | 5216000 |
| Application | Lot | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Max) | 2 | 8000 | ₹280000 |
| S-HNI (Min) | 3 | 12000 | ₹420000 |
Avg IPO Size (Sector Based):
₹ 21.71 cr.
Average Sector PE Ratio:
20.39 X
Listing Price:
₹ 35.00
Vijaypd Ceutical is engaged in the business of distributor and supplier of the pharmaceutical products and consumer goods sectors, offering a comprehensive range of services. Thier roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. They provide a wide range of products, serving both the pharmaceutical and wellness industries, as well as the fast moving consumer goods (FMCG) market, including pharmaceutical and wellness products such as medicines, including injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products; vitamins, hormones, enzymes, and wellness tonics; serums and diagnostic test kits, and fast-moving consumer goods, such as personal care and toiletries like soaps, sanitizers, and baby care items; ayurvedic product; cosmetics and food products and additionally, they provide dental products, crude drugs. Their Company VijayPD Ceutical Limited was originally incorporated as M/s. Vijay Pharma, as a partnership firm, in the year 1971 before being converted into a public limited company.
Further their Company has acquired the running business of M/s. P.D. Doshi, a Partnership firm on going concern basis vide Business Transfer Agreement dated April 1, 2024 entered by and between M/s. P.D. Doshi, Partnership firm and their company. A pharmaceutical supply chain consists of various stages, ranging from manufacturing to distribution and the delivery of medicines and vaccines to consumers. This supply chain encompasses several processes such as drug distribution, inventory management, pharmaceutical logistics, and overall supply chain management. In addition to these processes, it involves multiple entities, including manufacturers, suppliers, distributors, logistics partners, shippers and pharmaceutical retailers.
| Company Name | CMP | Face Value | Basic & Diluted EPS | PE Ratio | RoNW | NAV per Share |
|---|---|---|---|---|---|---|
| Vijaypd Ceutical Limited | 35 | 10 | 3.84 | 9.11 | 14.91 | 25.78 |
| Medplus Health Services Limited | 853.60 | 2 | 3.37 | 253.29 | 3.32 | 103.63 |
| Entero Healthcare Solutions Limited | 1,227.40 | 10 | 4.41 | 278.32 | 1.17 | 379.33 |
Smart Horizon Capital Advisors Private Limited, based in Mumbai is the Lead Manager (BRLM) of Vijaypd Ceutical IPO. Smart Horizon Capital Advisors Private Limited has handled (17) SME IPOs till date of which (76%) of the SME IPOs have been listed with listing gains. Read full review of Smart Horizon Capital Advisors Private Limited .
Vijaypd Ceutical IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Vijaypd Ceutical Financial Review Page
Merchant Banker(s) of Vijaypd Ceutical IPO: Smart Horizon Capital Advisors Private Limited
Vijaypd Ceutical IPO subscription was 1.37 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vijaypd Ceutical IPO listed at a listing price of 35.00 against the offer price of 35.00.
The current market price of Vijaypd Ceutical is 37.65.
Why Us?
